Watch KEYS here. Price has been getting very tight (see daily chart). Looks to be on the verge of breaking out
Keysight Technologies said it expects fourth quarter non-GAAP earnings of $1.42 to $1.48 per share on revenue of $1.17 billion to $1.19 billion. The current consensus earnings estimate is $1.26 per share on revenue of $1.14 billion for the quarter ending October 31, 2020. Normaly the share price should make an outbreak with more than 10% gain in the next weeks ahead.
Potential breakout on Fridays for KEYS after a earnings beat. Previous ATH sits at $110 which is first major resistance. Higher targets then sit at Fibonacci confluence @ $115 & $118 . Messy but possible Inverse H&S formed. PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
Earnings 8-20 I Felt the need to update this. My fault. I did not look close enough and apologize Possible B/O of ABC Pattern. Definite R at 110 and Keys did not break this last cycle. If I were to trade the ABC pattern I would make my targets 108 to 110ish do recall an earnings miss in May because I owned this )o: Some sell before earnings and I did not. ...
It needs to enter into that channel and stay above that bottom trend line.
It needs to enter that channel. Its at the border now. Once it breaks above the bottom trend line, it can reach 125. Stop loss 99.
A slanted Inverse head and shoulders has had it's neckline tested as a resistance on the daily the Measure Move would put you at around $77.60 but there's a then zone of support blocking you just b4 that level and after you break that there will be nothing until around $70.95 I laid out three profit taking zones here.
KEYS- Closed over 9ema finally, Opened over it, tested it intraday and closed at day highs. RSI trend break and MACD cross
Low RSI, could continue path higher, keep an eye on consolidation towards bottom line for indicator.
KEYS is showing a potential rising wedge on the daily at the 1.618 golden mean ratio fib extension. There is also coinciding weekly and daily bearish divergence on the MACD.